| Ytd | 3.30% | |
| 1y | 129.96% |
| Open | 104.91 | Prev Close | 104.91 | Low | 104.91 | High | 104.91 | Mkt Cap | 20.03B |
| Vol | 21.56M | Avg Vol | 2.53M | EPS | -1.10 | P/E | -95.37 | Forward P/E | 55.22 |
| Beta | 1.44 | Short Ratio | 3.23 | Inst. Own | 86.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 103.02 | 200-d Avg | 74.29 | 1yr Est | 106.30 |
Abbott Laboratories NYSE: ABT gave the market what it wanted in its Q2 earnings report, affirming th
Abbott Laboratories is upgraded to Buy ahead of Q2 2026 earnings, following a challenging period mar
Shares of Abbott Laboratories (NYSE:ABT) fell 3.2% on Thursday morning after the healthcare conglome
Capricorn Fund Managers Ltd acquired a new stake in shares of Exact Sciences Corporation (NASDAQ: EX
Exchange Traded Concepts LLC cut its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 39.6% dur
FNY Investment Advisers LLC acquired a new position in shares of Exact Sciences Corporation (NASDAQ:
Banque Pictet and Cie SA decreased its stake in Exact Sciences Corporation (NASDAQ: EXAS) by 77.0% i
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer sc
Bridgefront Capital LLC bought a new position in Exact Sciences Corporation (NASDAQ: EXAS) in the un
ArrowMark Colorado Holdings LLC boosted its position in shares of Exact Sciences Corporation (NASDAQ
Dimensional Fund Advisors LP raised its position in shares of Exact Sciences Corporation (NASDAQ: EX
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limite
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer sc
WILMINGTON, Del.--(BUSINESS WIRE)-- #AIinHealthcare--Amalgam Rx, Inc., a leader in data-driven, AI-p
DNB Asset Management AS boosted its position in Exact Sciences Corporation (NASDAQ: EXAS) by 15.5% i
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a lead
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
EXAS posts Q4 revenue beat as Screening and Precision Oncology grow, margins expand, shares tick up
Aberdeen Group plc raised its holdings in shares of Exact Sciences Corporation (NASDAQ: EXAS) by 52.
Discover last week's top 10 large-cap stock gainers, why they rallied, and what catalysts drove
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even th
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as s
Wall Street opened the week on a mixed note on Monday.
Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched an
All three major U.S. indices are red in Wednesday's midday trading as investors weighed Presiden
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly ear
Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The cent
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, l
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaini